sRAGE is associated with low waist circumference and Hb levels in NAFLD

sRAGE is associated with low waist circumference and Hb levels in NAFLD

Bibliographic Details
Main Authors:	Hyogo Hideyuki, Yamagishi Sho-ichi, Maeda Sayaka, Nakahara Takashi, Kimura Yuki, Chayama Kazuaki
Format:	Article
Language:	English
Published:	De Gruyter 2013-12-01
Series:	Open Medicine
Subjects:	srage nafld hemoglobin liver obesity
Online Access:	https://doi.org/10.2478/s11536-013-0224-z

Similar Items

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
by: Rui Wu, et al.
Published: (2020-10-01)

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a
by: Mahnoosh Rahimi, et al.
Published: (2018-03-01)

S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study
by: Philippe Joly, et al.
Published: (2017-11-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)
by: Sherif W. Mansour, et al.
Published: (2021-10-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
by: Andrea Maria Maresca, et al.
Published: (2019-02-01)

Soluble receptor for advanced glycation end products (sRAGE) and carotid intima-media thickness (CIMT) in type 1 diabetes Mellitus: Possible association with diabetic vascular complications
by: Eman M. Sherif, et al.
Published: (2014-10-01)

Differential Effects of Dry vs. Wet Heating of β-Lactoglobulin on Formation of sRAGE Binding Ligands and sIgE Epitope Recognition
by: Hannah E. Zenker, et al.
Published: (2019-06-01)

Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women
by: Nabigh A NAJI, et al.
Published: (2021-06-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
by: Franziska Diekmann, et al.
Published: (2021-08-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
by: Amelia K. Fotheringham, et al.
Published: (2020-09-01)

Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
by: Bogna Gryszczyńska, et al.
Published: (2020-05-01)

Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits
by: Ioannis-Alexandros Drosatos, et al.
Published: (2021-09-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health
by: Elena Dozio, et al.
Published: (2020-02-01)

Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
by: Valeria Manganelli, et al.
Published: (2019-03-01)

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01)

P.39 The Role of Advanced Glycation End Products in Vascular Ageing. Which Parameter is the Most Suitable as Biomarker?
by: Otto Mayer, et al.
Published: (2020-12-01)

Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
by: Maria Guarino, et al.
Published: (2019-09-01)

The Association between Pediatric NAFLD and Common Genetic Variants
by: Giuseppina Rosaria Umano, et al.
Published: (2017-06-01)

The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts
by: Cristina Iulia Mitran, et al.
Published: (2019-10-01)

Efek Kortikosteroid Dosis Rendah terhadap Kadar Soluble Receptor for Advanced Glycation End Products Mencit Balb/C Model Sepsis
by: Diding Heri Prasetyo, et al.
Published: (2015-03-01)

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
by: Buxing Chen, et al.
Published: (2012-09-01)

Crosstalk between PPARs and gut microbiota in NAFLD
by: Liwei Wu, et al.
Published: (2021-04-01)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-06-01)

Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
by: Bogna Gryszczyńska, et al.
Published: (2019-08-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

Dual Role of MicroRNAs in NAFLD
by: Valerio Nobili, et al.
Published: (2013-04-01)

Microbiota, Fiber, and NAFLD: Is There Any Connection?
by: Alejandra Pérez-Montes de Oca, et al.
Published: (2020-10-01)

Gut Microbiota and Lifestyle Interventions in NAFLD
by: David Houghton, et al.
Published: (2016-03-01)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-08-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: David Carneros, et al.
Published: (2020-11-01)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
by: Suzanne Miller, et al.
Published: (2016-01-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)